These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9464686)

  • 1. Beta-amyloid peptides as direct cholinergic neuromodulators: a missing link?
    Auld DS; Kar S; Quirion R
    Trends Neurosci; 1998 Jan; 21(1):43-9. PubMed ID: 9464686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer's disease.
    Kar S; Slowikowski SP; Westaway D; Mount HT
    J Psychiatry Neurosci; 2004 Nov; 29(6):427-41. PubMed ID: 15644984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease: interactions between cholinergic functions and beta-amyloid.
    Yan Z; Feng J
    Curr Alzheimer Res; 2004 Nov; 1(4):241-8. PubMed ID: 15975053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal forebrain cholinergic dysfunction in Alzheimer's disease--interrelationship with beta-amyloid, inflammation and neurotrophin signaling.
    Schliebs R
    Neurochem Res; 2005; 30(6-7):895-908. PubMed ID: 16187224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid beta peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures.
    Zheng WH; Bastianetto S; Mennicken F; Ma W; Kar S
    Neuroscience; 2002; 115(1):201-11. PubMed ID: 12401334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer's disease.
    Baker-Nigh A; Vahedi S; Davis EG; Weintraub S; Bigio EH; Klein WL; Geula C
    Brain; 2015 Jun; 138(Pt 6):1722-37. PubMed ID: 25732182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
    Kuznetsova E; Schliebs R
    Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [beta-Amyloid, cholinergic neurons and Alzheimer's disease].
    Kasparová J; Dolezal V
    Cesk Fysiol; 2002 May; 51(2):82-94. PubMed ID: 12053492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggregation state and neurotoxic properties of alzheimer β-amyloid peptide.
    Mohamed A; Cortez L; de Chaves EP
    Curr Protein Pept Sci; 2011 May; 12(3):235-57. PubMed ID: 21348837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of amyloid β-protein on hippocampal long-term potentiation].
    Zhang JF; Yang D; Qi JS
    Sheng Li Xue Bao; 2010 Dec; 62(6):479-88. PubMed ID: 21170492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiological roles of amyloid-beta and implications for its removal in Alzheimer's disease.
    Bishop GM; Robinson SR
    Drugs Aging; 2004; 21(10):621-30. PubMed ID: 15287821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
    Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
    Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid beta-peptide induces cholinergic dysfunction and cognitive deficits: a minireview.
    Tran MH; Yamada K; Nabeshima T
    Peptides; 2002 Jul; 23(7):1271-83. PubMed ID: 12128084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The basal forebrain cholinergic system in aging and dementia. Rescuing cholinergic neurons from neurotoxic amyloid-β42 with memantine.
    Nyakas C; Granic I; Halmy LG; Banerjee P; Luiten PG
    Behav Brain Res; 2011 Aug; 221(2):594-603. PubMed ID: 20553766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular approaches to the treatment, prophylaxis, and diagnosis of Alzheimer's disease: tangle formation, amyloid-β, and microglia in Alzheimer's disease.
    Takata K; Kitamura Y
    J Pharmacol Sci; 2012; 118(3):331-7. PubMed ID: 22382659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease.
    Karthick C; Nithiyanandan S; Essa MM; Guillemin GJ; Jayachandran SK; Anusuyadevi M
    Neurol Res; 2019 Feb; 41(2):139-150. PubMed ID: 30453864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attempts to make models for Alzheimer's disease.
    Shiosaka S
    Neurosci Res; 1992 May; 13(4):237-55. PubMed ID: 1321388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cholinergic system in aging and neuronal degeneration.
    Schliebs R; Arendt T
    Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-amyloid: a disease target or a synaptic regulator affecting age-related neurotransmitter changes?
    Mura E; Lanni C; Preda S; Pistoia F; Sarà M; Racchi M; Schettini G; Marchi M; Govoni S
    Curr Pharm Des; 2010; 16(6):672-83. PubMed ID: 20388077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of A beta 42 in Alzheimer's disease.
    Younkin SG
    J Physiol Paris; 1998; 92(3-4):289-92. PubMed ID: 9789825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.